These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 374928)

  • 21. Inability to deactivate the sympathetic nervous system in patients with brainstem infarction; correction of the disorder by centrophenoxine administration.
    Stoica E; Enulescu O; Nicolae A
    Neurol Psychiatr (Bucur); 1983; 21(4):425-39. PubMed ID: 6419342
    [No Abstract]   [Full Text] [Related]  

  • 22. [Captagon--a new psychotonic agent].
    Bryś J; Tomaszewski K; Wasik A; Bukowczyk A
    Psychiatr Pol; 1969; 3(3):341-6. PubMed ID: 5805112
    [No Abstract]   [Full Text] [Related]  

  • 23. [Determination of the anti-anoxia capacity of drugs].
    Truchaud M
    Sem Hop Ther; 1977 Nov; 53(9):425-9. PubMed ID: 341317
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment results with Cerutil in age-related cerebral insufficiency in general medicine].
    Richter K
    Z Alternsforsch; 1983; 38(1):63-9. PubMed ID: 6405547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proceedings: Effects of centrophenoxine and palmitoylethanolamide in rats with early protein and calorie malnutrition. I. Neurological tests.
    Tikal K; Benesová O; Hvizdosovă J
    Act Nerv Super (Praha); 1974; 16(4):253-4. PubMed ID: 4218051
    [No Abstract]   [Full Text] [Related]  

  • 26. [Are animal experiments and clinical prevention of abnormalities possible?].
    Neumann HJ
    Zentralbl Gynakol; 1986; 108(20):1222-7. PubMed ID: 3101316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proceedings: The effects of centrophenoxine and palmitoylethanolamide in rats with early protein and calorie malnutrition. II. Somatic and biochemical parameters.
    Hvizdosová J; Benesová O; Tikal K
    Act Nerv Super (Praha); 1974; 16(4):355-6. PubMed ID: 4218052
    [No Abstract]   [Full Text] [Related]  

  • 28. [Psychopharmacotherapy and problems of delineating borderline forms of neuropsychic disorders].
    Aleksandrovskii IuA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1974; 74(11):1713-7. PubMed ID: 4450901
    [No Abstract]   [Full Text] [Related]  

  • 29. Trazodone in the treatment of psychoneuroses: a double-blind study.
    Antonelli F; De Gregorio M; Dionisio A
    Curr Ther Res Clin Exp; 1973 Oct; 15(10):799-804. PubMed ID: 4201978
    [No Abstract]   [Full Text] [Related]  

  • 30. [Dyscalculia in the child. Differential diagnostic].
    Hasaerts-van Geertruyden E
    Rev Neuropsychiatr Infant; 1975; 23(10-11):665-77. PubMed ID: 1209066
    [No Abstract]   [Full Text] [Related]  

  • 31. [Study of the effect of centrophenoxine on experimental animals poisoned with chlordiazepoxide].
    Mirchev N
    Eksp Med Morfol; 1975; 14(4):225-7. PubMed ID: 770143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Familial learning disability, easy fatigue and maladroitness: preliminary trial of monosodium glutamate in adults.
    Kripke B; Lynn R; Madsen JA; Gay PE
    Dev Med Child Neurol; 1982 Dec; 24(6):745-51. PubMed ID: 6759270
    [No Abstract]   [Full Text] [Related]  

  • 33. [Experimental study of oxaflumazine acid disuccinate in the treatment of 24 cases of psychotic children in a pedopsychiatric environment].
    Sichel JP; Poupier G
    Rev Neuropsychiatr Infant; 1972; 20(3):367-74. PubMed ID: 5055026
    [No Abstract]   [Full Text] [Related]  

  • 34. [Personality and sensory-motor perversions of ocular origin].
    Davy C
    Rev Neuropsychiatr Infant; 1976 Dec; 24(12):669-95. PubMed ID: 1013575
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical experimetation with Piracetam].
    Dubois B; Fontaine G
    Lille Med; 1973; 18(7):832-5. PubMed ID: 4152650
    [No Abstract]   [Full Text] [Related]  

  • 36. Pemoline: review of performance.
    Plotnikoff N
    Tex Rep Biol Med; 1971; 29(4):467-79. PubMed ID: 4337779
    [No Abstract]   [Full Text] [Related]  

  • 37. Prediction of the stability of meclofenoxate injection in parenteral admixtures.
    Koshiro A; Fujita T
    Drug Intell Clin Pharm; 1981 May; 15(5):331-7. PubMed ID: 6791905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differences between the effects of two meclofenoxate doses on active training for two-way avoidance in rats.
    Petkov VV; Vaglenova J
    Acta Physiol Pharmacol Bulg; 1986; 12(4):36-41. PubMed ID: 3107344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Value of 1694 for children with cerebral palsy of those presenting psychomotor development disorders].
    Kohler C; Kamoun A; Gailly MT
    Rev Neuropsychiatr Infant; 1976; 24(1-2):57-60. PubMed ID: 769132
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment with Tegretal in children's convulsion disease].
    Wünsche W; Todt H; Munde B
    Dtsch Gesundheitsw; 1971 Apr; 26(16):745-9. PubMed ID: 4995961
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.